|
1
|
World Health Organization (WHO), . Global
tuberculosis control: Surveillance, planning, financing: WHO report
2008. WHO; Geneva: 2008
|
|
2
|
Maher D, Watt CJ, Williams BG, Raviglione
M and Dye C: Tuberculosis deaths in countries with high HIV
prevalence: what is their use as an indicator in tuberculosis
programme monitoring and epidemiological surveillance? Int J Tuberc
Lung Dis. 9:123–127. 2005.PubMed/NCBI
|
|
3
|
Cohn DL, Bustreo F and Raviglione MC:
International Union Against Tuberculosis and Lung Disease:
Drug-resistant tuberculosis: Review of the worldwide situation and
the WHO/IUATLD Global Surveillance Project. Clin Infect Dis.
24:(Suppl 1). S121–S130. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fine PE: Variation in protection by BCG:
Implications of and for heterologous immunity. Lancet.
346:1339–1345. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kaufmann SHE: Envisioning future
strategies for vaccination against tuberculosis. Nat Rev Immunol.
6:699–704. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kaufmann SHE: Recent findings in
immunology give tuberculosis vaccines a new boost. Trends Immunol.
26:660–667. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McShane H, Pathan AA, Sander CR,
Goonetilleke NP, Fletcher HA and Hill AV: Boosting BCG with MVA85A:
The first candidate subunit vaccine for tuberculosis in clinical
trials. Tuberculosis (Edinb). 85:47–52. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goonetilleke NPMH, McShane H, Hannan CM,
Anderson RJ, Brookes RH and Hill AV: Enhanced immunogenicity and
protective efficacy against Mycobacterium tuberculosis of bacille
Calmette-Guérin vaccine using mucosal administration and boosting
with a recombinant modified vaccinia virus Ankara. J Immunol.
171:1602–1609. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferraz JC, Stavropoulos E, Yang M, Coade
S, Espitia C, Lowrie DB, Colston MJ and Tascon RE: A heterologous
DNA priming-Mycobacterium bovis BCG boosting immunization strategy
using mycobacterial Hsp70, Hsp65, and Apa antigens improves
protection against tuberculosis in mice. Infect Immun.
72:6945–6950. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Palendira U, Spratt JM, Britton WJ and
Triccas JA: Expanding the antigenic repertoire of BCG improves
protective efficacy against aerosol Mycobacterium tuberculosis
infection. Vaccine. 23:1680–1685. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu Y, Zhu B, Wang Q, Chen J, Qie Y, Wang J
and Wang H, Wang B and Wang H: Recombinant BCG coexpressing Ag85B,
ESAT-6 and mouse-IFN-γ confers effective protection against
Mycobacterium tuberculosis in C57BL/6 mice. FEMS Immunol Med
Microbiol. 51:480–487. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang BL, Xu Y, Wu CQ, Xu YM and Wang HH:
Cloning, expression, and refolding of a secretory protein ESAT-6 of
Mycobacterium tuberculosis. Protein Expr Purif. 39:184–188. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu Y, Wang B, Chen J, Wang Q, Zhu B, Shen
H, Qie Y, Wang J and Wang H: Chimaeric protein improved
immunogenicity compared with fusion protein of Ag85B and ESAT-6
antigens of Mycobacterium tuberculosis. Scand J Immunol.
64:476–481. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Romano M, Rindi L, Korf H, Bonanni D,
Adnet PY, Jurion F, Garzelli C and Huygen K: Immunogenicity and
protective efficacy of tuberculosis subunit vaccines expressing
PPE44 (Rv2770c). Vaccine. 26:6053–6063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Flynn JL and Chan J: Immunology of
tuberculosis. Annu Rev Immunol. 19:93–129. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jung YJ, LaCourse R, Ryan L and North RJ:
Evidence inconsistent with a negative influence of T helper 2 cells
on protection afforded by a dominant T helper 1 response against
Mycobacterium tuberculosis lung infection in mice. Infect Immun.
70:6436–6443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roach DR, Bean AG, Demangel C, France MP,
Briscoe H and Britton WJ: TNF regulates chemokine induction
essential for cell recruitment, granuloma formation, and clearance
of mycobacterial infection. J Immunol. 168:4620–4627. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Keane J, Gershon S, Wise RP,
Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN and Braun
MM: Tuberculosis associated with infliximab, a tumor necrosis
factor alpha-neutralizing agent. N Engl J Med. 345:1098–1104. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pfeffer K: Biological functions of tumor
necrosis factor cytokines and their receptors. Cytokine Growth
Factor Rev. 14:185–191. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tully G, Kortsik C, Höhn H, Zehbe I,
Hitzler WE, Neukirch C, Freitag K, Kayser K and Maeurer MJ: Highly
focused T cell responses in latent human pulmonary Mycobacterium
tuberculosis infection. J Immunol. 174:2174–2184. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brookes RH, Pathan AA, McShane H, Hensmann
M, Price DA and Hill AV: CD8+ T cell-mediated
suppression of intracellular Mycobacterium tuberculosis growth in
activated human macrophages. Eur J Immunol. 33:3293–3302. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brodin P, Rosenkrands I, Andersen P, Cole
ST and Brosch R: ESAT-6 proteins: Protective antigens and virulence
factors? Trends Microbiol. 12:500–508. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
D'Souza S, Rosseels V, Romano M, Tanghe A,
Denis O, Jurion F, Castiglione N, Vanonckelen A, Palfliet K and
Huygen K: Mapping of murine Th1 helper T-Cell epitopes of mycolyl
transferases Ag85A, Ag85B, and Ag85C from Mycobacterium
tuberculosis. Infect Immun. 71:483–493. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brandt L, Elhay M, Rosenkrands I, Lindblad
EB and Andersen P: ESAT-6 subunit vaccination against Mycobacterium
tuberculosis. Infect Immun. 68:791–795. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
De Rosa SC, Lu FX, Yu J, Perfetto SP,
Falloon J, Moser S, Evans TG, Koup R, Miller CJ and Roederer M:
Vaccination in humans generates broad T cell cytokine responses. J
Immunol. 173:5372–5380. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Makedonas G and Betts MR: Polyfunctional
analysis of human t cell responses: Importance in vaccine
immunogenicity and natural infection. Springer Semin Immunopathol.
28:209–219. 2006. View Article : Google Scholar : PubMed/NCBI
|
